Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Early signs of memory impairment among multiple sclerosis patients with clinically isolated syndrome.
Fatigue and fatigability in neurologic illnesses: Proposal for a unified taxonomy.
Low vitamin B12 levels and gastric parietal cell antibodies in patients with aquaporin-4 antibody-positive neuromyelitis optica spectrum disorders.
Reproductive issues in women with multiple sclerosis: ethical considerations.
Multiple sclerosis: current and emerging disease-modifying therapies and treatment strategies.
Changes in Cognitive Processing Speed, Mood, and Fatigue in an Observational Study of Persons With Multiple Sclerosis Treated With Dalfampridine-ER.
Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS.
[Controlled research on multiple sclerosis treated with electroacupuncture and acupoint injection].
1,25-Dihydroxyvitamin D3 selectively and reversibly impairs T helper-cell CNS localization.
A Study to Evaluate the Effectiveness, Tolerability and Safety of Laquinimod
Identifying autoantigens in demyelinating diseases: valuable clues to diagnosis and treatment?
[Vitamin D for prevention of diseases?].
A qualitative exploration of the impact of a 12-week group exercise class for those moderately affected with multiple sclerosis.
Imaging In The Cell
Gray matter is targeted in first-attack multiple sclerosis.
Disease-modifying therapies in Chinese children with multiple sclerosis.
MRI in multiple sclerosis: an intra-individual, randomized and multicentric comparison of gadobutrol with gadoterate meglumine at 3 T.
1,25-Dihydroxyvitamin D3 acts directly on the T lymphocyte vitamin D receptor to inhibit experimental autoimmune encephalomyelitis.
An Intricate Mechanism of Action of Avonex in Relapsing Remitting Multiple Sclerosis Patients: Variation of Serum Titre of Interleukin-17A, Interleukin-10 and Transforming Growth Factor-β.
Switching From Natalizumab to Fingolimod in Multiple Sclerosis: A French Prospective Study.
The VP1 subunit of JC polyomavirus recapitulates early events in viral trafficking and is a novel tool to study polyomavirus entry.
Multiple sclerosis treatment: current best practice.
Safety, efficacy, and pharmacokinetics/pharmacodynamics of daclizumab (anti-CD25) in patients with adult T-cell leukemia/lymphoma.
Iron and Non-Iron-Related Characteristics of Multiple Sclerosis and Neuromyelitis Optica Lesions at 7T MRI.
Solodyn
Pages
« first
‹ previous
…
159
160
161
162
163
164
165
166
167
…
next ›
last »